Craft

Mesa Laboratories

Stock Price

$112.7

2024-10-29

Market Capitalization

$610.7 M

2024-10-29

Revenue

$249.1 M

FY, 2026

Mesa Laboratories Summary

Company Summary

Overview
Mesa Laboratories is a company that designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. It operates through four segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures biological, chemical, and cleaning indicators used to evaluate sterilization and cleaning processes and provides laboratory testing services. The Clinical Genomics segment develops genetic analysis tools and consumables for applications such as inherited disease testing, oncology, and pharmacogenetics. The Biopharmaceutical Development segment produces instruments and consumables for protein analysis and peptide synthesis. The Calibration Solutions segment provides quality control instruments and systems for measuring and calibrating environmental and process parameters in medical and industrial settings.
Type
Public
Status
Active
Founded
1982
HQ
Lakewood, CO, US | view all locations
Website
https://mesalabs.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Gary Owens

    Gary Owens, President, Chief Executive Officer, Director

  • John V. Sakys

    John V. Sakys, Chief Financial Officer

  • Brian Archbold

    Brian Archbold, Senior Vice President, Continuous Improvement

  • Mark Vossenaar

    Mark Vossenaar, Vice President and General Manager

Operating MetricsView all

Business Segments

4

FY, 2023

Facilities Leased, sq. ft.

11
10.0%

FY, 2023

Backlog

$38.1M
78.9%

FY, 2023

LocationsView all

4 locations detected

  • Lakewood, CO HQ

    United States

    12100 West 6th Ave.

  • Bozeman, MT

    United States

    625 Zoot Way

  • Saint-Priest, Auvergne-Rhône-Alpes

    France

    2 Rue Auguste Fresnel

  • München, BY

    Germany

    Sigmund-Riefler-Bogen 19

Mesa Laboratories Financials

Summary Financials

Revenue (FY, 2026)
$249.1M
Gross profit (FY, 2026)
$158.3M
Net income (FY, 2026)
$6.7M
Cash (FY, 2026)
$26.9M
EBIT (FY, 2026)
$18.5M
Enterprise value
$693.2M

Footer menu